| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |